Update - neuraxis announces new medical policy coverage with a prominent insurer for over five million lives across multiple states

Carmel, ind., jan. 21, 2025 (globe newswire) -- neuraxis, inc. ("neuraxis," or the "company") (nyse american: nrxs), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced medical policy coverage for percutaneous electrical nerve field stimulation (penfs), with a prominent insurer, with approximately 5.1 million members across 13 states.
NRXS Ratings Summary
NRXS Quant Ranking